Trial intelligence / Profile preview

Neurontin vs Ativan for Alcohol Withdrawal

NCT00011297Phase 2Completed

Sponsor
National Institute on Alcohol Abuse and Alcoholism
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gabapentin in alcohol withdrawal syndrome (AWS), sponsored by National Institute on Alcohol Abuse and Alcoholism. Status: completed.

02

Drugs

gabapentin
03

Conditions

alcohol withdrawal syndrome (AWS)

Beyond the preview

Go deeper on NCT00011297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00011297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call